Aspartoacylase (ASPA) Peptide
ASPA
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN939419
Quick Overview for Aspartoacylase (ASPA) Peptide (ABIN939419)
Target
ASPA
(Aspartoacylase (ASPA))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Peptide Type
- Synthetic
-
Sequence
- IKTSLAPLPC YVYLIEHPSL KYATTRSIAK YPVGIEVGPQ PQGVLRADIL
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of ASPA antibody,
Alternative Names: ASPA control peptide, ASPA antibody Blocking Peptide, Anti-ASPA Blocking Peptide, Aspartoacylase Blocking Peptide, Canavan Disease Blocking Peptide, ACY2 Blocking Peptide, ASP Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- ASPA (Aspartoacylase (ASPA))
-
Background
- ASPA catalyzes the deacetylation of N-acetylaspartic acid (NAA) to produce acetate and L-aspartate. NAA occurs in high concentration in brain and its hydrolysis NAA plays a significant part in the maintenance of intact white matter. In other tissues it acts as a scavenger of NAA from body fluids.
-
Molecular Weight
- 36 kDa
Target
-
You are here:
